PCVX
Vaxcyte Inc
Price:  
91.05 
USD
Volume:  
528,074.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PCVX WACC - Weighted Average Cost of Capital

The WACC of Vaxcyte Inc (PCVX) is 9.3%.

The Cost of Equity of Vaxcyte Inc (PCVX) is 14.90%.
The Cost of Debt of Vaxcyte Inc (PCVX) is 5.00%.

Range Selected
Cost of equity 12.80% - 17.00% 14.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.2% - 10.3% 9.3%
WACC

PCVX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.93 2.17
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.80% 17.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 8.2% 10.3%
Selected WACC 9.3%